Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Analysis of Mortality in Subjects Who Participated in Three Studies of Galantamine in Mild Cognitive Impairment

NCT00297414 is registered in ClinicalTrials.gov with Johnson & Johnson Pharmaceutical Research & Development, L.L.C. as lead sponsor.

NCT NCT00297414
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00297414 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Analysis of Mortality in Subjects Who Participated in Three Studies of Galantamine in Mild Cognitive Impairment
Lead sponsor
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Phase
Observational
Overall status
Completed
Start date
June 30, 2004
Completion date
January 31, 2005
Enrollment
1,083 (actual)
Sites
144

Conditions

As the registry lists them; a condition with its own page is linked.

mild cognitive impairment